Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 2018 September;30(3) > Minerva Biotecnologica 2018 September;30(3):75-81

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Minerva Biotecnologica 2018 September;30(3):75-81

DOI: 10.23736/S1120-4826.18.02404-7

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Basic and clinical aspects of resistin

Chiara ROSSO 1 *, Gian P. CAVIGLIA 1, Sharmila FAGOONEE 2, Elisabetta BUGIANESI 1, Giorgio M. SARACCO 1

1 Division of Gastroenterology and Hepatology, Department of Medical Sciences, University of Turin, Turin, Italy; 2 Institute for Biostructures and Bioimages (CNR) c/o Molecular Biotechnology Center, Turin, Italy


PDF


Resistin is a peptide hormone belonging to the class of cysteine-rich secreted proteins involved in the modulation of inflammation and immunity, particularly in insulin-resistant states. Circulating levels of resistin are elevated in obesity, diabetes and other chronic inflammatory conditions such as inflammatory bowel disease. However, the pathogenic role of resistin in the onset and progression of these diseases is not completely understood and the partial homology of resistin in animal models compared to humans limits our understanding of its physiological role. This review aims to summarize the main mechanisms linking resistin to inflammation as well as its clinical significance in different chronic liver and gastrointestinal diseases.


KEY WORDS: Resistin - Adipokines - Inflammation

top of page